Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy |
| March 05, 2021 | March 2021 Bond Updates |
|
STOCKHOLM, March 5, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy, Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration. Monaco brings robust functionality for proton... |
| View more at: https://www.prnewswire.com:443/news-releases/elekta-and-iba-strengthen-partnership-to-help-cancer-centers-integrate-proton-therapy-301241282.html |
| Related News |
|